Risk factors for renal impairment in patients with hematological cancer receiving antineoplastic treatment.

Priscila Nunes Costa TravassosPaulo Goberlânio de Barros SilvaMilena Oliveira FreitasMarcus Davis Machado BragaFernando Barroso DuarteJéssica Karen de Oliveira MaiaHelena PitombeiraJacqueline Holanda de SousaAna Paula Negreiros Nunes Alves

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)

The prevalence of renal disorders was high in patients with oncohematological neoplasms receiving antineoplastic treatment. This requires periodic monitoring of the evaluation of renal function since reductions in GFRs were significantly associated with different treatment protocols used.

Keyphrases

combination therapy
young adults